Retinal Vein Occlusions Bibliography

Downloads  Fellow Members Only

Campochiaro PA, Clark WL, Boyer DS, et al. Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion. Ophthalmology. 2015;122(3):538-544.

The Central Vein Occlusion Study Group N Report. A Randomized Clinical Trial of Early Panretinal Photocoagulation for Ischemic Central Vein Occlusion. Ophthalmology. 1995;102(10):1434-1444

Branch Vein Occlusion Study Group. Argon Laser Scatter Photocoagulation for Prevention of Neovascularization and Vitreous Hemorrhage in Branch Vein Occlusion. A Randomized Clinical Trial. Arch Ophthalmol. 1986;104(1):34-41

Campochiaro PA, Brown DM, Awh CC, et al. Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study. Ophthalmology. 2011;118(10):2041–2049

Scott IU, Ip MS, VanVeldhuisen PC, et al; SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol. 2009;127(9):1115-1128.

Campochiaro PA, Heier JS, Feiner L, et al, BRAVO Investi-gators. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010;117:1102–1112.

Brown DM, Campochiaro PA, Singh RP, et al, CRUISE Investigators. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010;117:1124–1133.

Brown, D.M., Heier, J.S., Clark, W.L. et al. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study. Am J Ophthalmol. 2013;155:429–437.

Campochiaro PA, Clark WL, Boyer DS, et al. Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: The 24-Week Results of the VIBRANT Study. Ophthalmology. 2015;122:538-544.

Central Vein Occlusion Study Group. Natural History and Clinical Management of Central Retinal Vein Occlusion. Arch Ophthalmol 1997;115:486-91.

Branch Vein Occlusion Study Group. Argon Laser Photocoagulation for Macular Edema in Branch Vein Occlusion. Am J Ophthalmol 1984;98:271-82.

Ip MS, Scott IU, VanVeldhuisen PC, et al, SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009;127:1101-14.

Haller JA, Bandello F, Belfort R Jr, et al, Ozurdex GENEVA Study Group. Randomized, sham controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117:1134-46.